Paróczai Dóra ERS előadásai:

ERS Congress 2023 Milan 9-13 September, 2023

Szóbeli prezentáció: Dóra Paróczai, Robbe Vermoesen, Helena Aegerter, Bart N. Lambrecht: GM-CSF increases uptake of Charcot-Leyden crystals in neutrophils and can induce NETopathic airway inflammation

Poszter prezentáció: Dóra Paróczai, András Bikov, Andreea Blidaru, Emanuel Bobu, Bianca Cerbu, Iosif Marincu, Stefan Mihaicuta, Stefan Fren: Lopinavir-ritonavir versus darunavir-norvir for hospitalized COVID-19 patients

Társszerző ( szóbeli prezentáció): Stefan-Marian Frent (Timisoara, Romania), Graham Giles, Dora Paroczai, Voicu Tudorache, Iosif Marincu, Oana Raduna, Sorin Herban, Marius Marcu, Flavius Pater, Fergus Law, Martin Wise, Cristian Oancea: Subtle Pulse Electro-biological Recovery Apparatus (SPERA) as anti-inflammatory treatment for COVID-19 – A Proof of Concept Study

 

ERS Congress 2022, Barcelona, 4-6 September 2022:

Dora Paroczai, Katrien Eger on behalf of SHARP CRC: The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?- poster presentation

 

ERS (European Respiratory Society) International Virtual Congress 05-08/09/2021, E-poster:

The effects of fluticasone propionate in mice infected with Chlamydia pneumoniae

D. Paróczai, A. Sejben, D. Kókai, D. Virok, V. Endrész, K. Burián

 

ERS (European Respiratory Society) International Virtual Congress 07-09/09/2020, E-posters

  • Prevalence of Chlamydia pneumoniae antibodies in Southern Hungary European Respiratory Journal 2020; 56: Suppl. 64, 2078.
  • The effects of inhaled corticosteroids and a beta-2 agonist on C. pneumoniae-infected airway epithelial cells European Respiratory Journal 2020; 56: Suppl. 64, 2336.

 

European Respiratory Society International Congress, Madrid, 28 September- 2 October 2019.

Dóra Paróczai, Tímea Mosolygó, Dávid Kókai, Ildikó Lantos, Dezső Virok, Zoltán Rózsavölgyi, Regina Pálföldi, Attila Somfay, Katalin Burián

C. pneumoniae serostatus influences cytokine production patterns in steroid resistant and sensitive asthmatics (European Respiratory Journal 2019 54: PA4395)